Medical/Pharmaceuticals
Vieworks to Highlight Its X-ray Flat Panel Detectors Lineup at ECR 2022
ANYANG, South Korea, July 6, 2022 /PRNewswire/ -- Vieworks, a global digital
X-ray imaging solution provider based inSouth Korea, is showcasing its 3rd
generation DR detectors and its latest dynamic detectors at ECR 2022 (Expo3
#322) fromJuly 13th to 17th.
Farrer Park Hospital Underscores Commitment to Sustainability with Ongoing Green Initiatives
SINGAPORE, July 6, 2022 /PRNewswire/ -- Sustainability efforts were already embedded in Farrer Park Hospital's ("FPH" or "the Hospital") DNA since its early phase of conceptualisation. Since FPH went operational in 2014, the Hospital has attained optimal energy savings of 30 per cent annually....
Inmagene and HUTCHMED Announce First Participants in Global Phase I Trial of IMG-007
SAN DIEGO and HONG KONG and SYDNEY, July 6, 2022 /PRNewswire/ -- Inmagene
Biopharmaceuticals ("Inmagene
harrison.ai and Sonic Healthcare join forces to launch 'franklin.ai', bringing Artificial Intelligence (AI) to pathology
franklin.ai aims to apply the latest methodologies in artificial intelligence
(AI) to putgroundbreaking AI tools into the hands of pathologists.
SYDNEY, July 6, 2022 /PRNewswire/ -- harrison.ai
Esco Lifesciences Group Strengthens IVF Portfolio by Acquiring Evidence Solution
SINGAPORE, July 6, 2022 /PRNewswire/ -- Esco Lifesciences Group ("Esco", the "Company") announces the full acquisition of Evidence Solution ("Evidence"), a Danish software company offering In Vitro Fertilization (IVF) management technologies and quality management systems ("Evidence witness syste...
Ascletis Announces U.S. IND Filing of Oral RdRp Inhibitor Drug Candidate ASC10 for COVID-19
-- ASC10 is an oral small molecule drug candidate, which is in-house discovered and developed, and Ascletis retains full global rights for its development and commercialization --This IND filing of ASC10 in the U.S. will accelerate Ascletis' global multi-center clinical studies on ASC10 and bett...
Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2022
Added 16,423 New Subscribers in 4QFY22 4QFY22 Revenues Down 1.7% YoY to RMB297.2 Million ($46.9 Million) 4QFY22 Gross Profit Down 0.5% YoY to RMB255.2 Million ($40.3 Million) 4QFY22 Operating Income Down 4.1% YoY to RMB142.1 Million ($22.4 Million) 4QFY22 Non-GAAP Operating Income Down 4.1% YoY ...
Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2022
Added 16,423 New Subscribers in 4QFY22 4QFY22 Revenues Down 1.7% YoY to RMB297.2 Million ($46.9 Million) 4QFY22 Gross Profit Down 0.5% YoY to RMB255.2 Million ($40.3 Million) 4QFY22 Operating Income Down 4.1% YoY to RMB142.1 Million ($22.4 Million) 4QFY22 Non-GAAP Operating Income Down 4.1% YoY ...
Eurofins Discovery Announces Acquisition of DiscoveryBioMed
SAN DIEGO, July 6, 2022 /PRNewswire/ -- Eurofins Discovery, the leading brand with over 35 years of success providing a complete solution of products and services for drug discovery, today announced the acquisition of DiscoveryBioMed, a contract research organization (CRO) focused on developing ...
Novavax Nuvaxovid™ COVID-19 Vaccine Conditionally Authorized in the European Union for Adolescents Aged 12 Through 17
* Nuvaxovid™ COVID-19 vaccine is the first protein-based option for adolescents aged 12 through 17 inEurope GAITHERSBURG, Md., July 5, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious inf...
Winner Medical Acquires 100% Stake in Guilin Latex, Expanding into Medical Latex Market
SHENZHEN, China, July 5, 2022 /PRNewswire/ -- Winner Medical Co. Ltd. (300888.SZ; "Winner Medical" and "the Company"), a leading manufacturer of disposable wound care and surgical products, held an inauguration ceremony for Winner (Guilin) Latex Products Co., Ltd in Guilin,Guangxi Province on Jun...
EditForce and Mitsubishi Tanabe Pharma Enter into License Agreement
FUKUOKA, Japan, July 5, 2022 /PRNewswire/ -- EditForce, Inc. (Headquarters: Fukuoka, President and CEO: Takashi Ono; hereinafter "EditForce") has entered into a License Agreement (hereinafter "Agreement") with Mitsubishi Tanabe Pharma Corporation (Headquarters:Osaka, Representative Director: Hiro...
NHS Scotland awards national laboratory medicine framework to Citadel Health
EDINBURGH, Scotland, July 5, 2022 /PRNewswire/ -- Scotland is on its way to
becoming home to the UK's largest connected laboratory medicine network,
following the appointment ofCitadel Health
Endurance RP Limited (SEHK:0575.HK) Operational Update on the PE Prevention Drug Fortacin™ / Senstend™
Phase 3 Study in China is Estimated to Complete in November 2022 HONG KONG, July 5, 2022 /PRNewswire/ -- Endurance RP Limited ("Endurance Longevity" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK) is pleased to provide updates on the PE prevention drug - Fo...
Breakthrough radiology AI provider annalise.ai appoints proven global healthcare leader as CEO, officially launches US team following FDA clearances
Seasoned health technology executive Lakshmi Gudapakkam to become CEO and former HCA Healthcare, Inc. executive DrRick Abramson appointed as Chief Medical Officer. New leadership team to drive expansion of world's first comprehensive AI radiology platform globally and entry into the US. CADt F...
QunaSys co-hosts industry, government leaders for Pistoia Alliance Global Knowledge-Sharing virtual event
Event focuses on real-world use cases for new technologies, including quantum, poised to improve health and the life sciences TOKYO, July 4, 2022 /PRNewswire/ -- QunaSys, a global leader in the development of innovative quantum algorithms in chemistry and a Pistoia Alliance member company, will ...
ClinChoice Raises $150 mm Series E Round Financing, Further Strengthening its Global Services Capabilities
PHILADELPHIA, July 4, 2022 /PRNewswire/ -- Recently, ClinChoice announced the successful completion of its $150 mm Series E round financing. The investment was led by Legend Capital, and co-invested by Taikang Life Insurance, Sherpa Healthcare Partners and existing shareholders, including Lilly A...
Arctic Vision Announces First Patient Enrolled in Phase III Clinical Trial of ARVN003 for Presbyopia
This is the first clinical trial approved in China for presbyopia drugs and Arctic Vision's study marks the first patient enrollment in a Phase III clinical trial for presbyopia drugs inChina. ARVN003 is expected to be the first approved drug for presbyopia inChina. SHANGHAI, July 4, 2022 /PRNew...
Bumrungrad International Hospital, Southeast Asia's Largest Hospital to Deploy Lunit's AI Cancer Screening System
* Lunit and FujiFilm Thailand to supply Lunit INSIGHT CXR and Lunit INSIGHT MMG to one of SEA's largest hospital using Microsoft Azure * Aim to detect cancer in early stages and spearhead medical innovation through AI across the SEA region SEOUL, South Korea, July 4, 2022 /PRNewswire/ -- Luni...
JW Therapeutics Announces Initiation of Clinical Study of JWATM204 in Patients with Advanced Hepatocellular Carcinoma
SHANGHAI, July 4, 2022 /PRNewswire/ -- JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, announced the initiation of phase I clinical study of JWATM204 in patients with advanced ...
Week's Top Stories
Most Reposted
SALMON SECURES $140 MILLION (PHP 8.8 BILLION) TO DOUBLE DOWN ON THE GROWTH OPPORTUNITY IN THE PHILIPPINES
[Picked up by 282 media titles]
2026-10-19 13:18Infobip and Yamaha Power Conversational Customer Engagement in Indonesia's Automotive Sector
[Picked up by 275 media titles]
2026-10-21 15:00DayOne Supports NVIDIA DSX POD Reference Design, Advancing Standardized Infrastructure for AI
[Picked up by 270 media titles]
2026-10-22 11:55Carro Establishes Inaugural SGD450 Million Asset-Backed Securitisation Warehouse Facility
[Picked up by 267 media titles]
2026-10-22 11:00Ready Server Launches ReadyServer LLM API, Giving Every VPS Customer Private AI Inference at No Extra Cost
[Picked up by 265 media titles]
2026-10-20 14:10